Agree, looking for $23 at minimum within 2 months. Earnings call was solid in all metrics, multiple expansion is justified.
Order bookings were very good, margin improved, cash is now 175.7 million, ( $2.71 per share )no debt, 3.20% divi is very nice, very nice growth in life science segment- all for a $10 stock.
I had already started nibbling on Friday. Guess I'll have to nibble a few more. Take a good look at Mazor. I know you are are deep value guy, but the street pays for growth and Mazor will treat you well. My other holdings are RGEN,NVDQ,ACAD,TTPH,BABY,AP, and a large slug of VOXX I bought after the huge sell down last week.